Related references
Note: Only part of the references are listed.Does Pen Help? A Real-World Outcomes Study of Switching from Vial to Disposable Pen Among Insulin Glargine-Treated Patients with Type 2 Diabetes Mellitus
Lin Xie et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2013)
Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes
Philip Levin et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Impact of Hypoglycemia Associated With Antihyperglycemic Medications on Vascular Risks in Veterans With Type 2 Diabetes
Yingnan Zhao et al.
DIABETES CARE (2012)
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi et al.
DIABETES CARE (2012)
Metabolic control and risk of hypoglycaemia during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis
A. E. Pontiroli et al.
DIABETES OBESITY & METABOLISM (2012)
Strategies for insulin initiation: insights from the French LIGHT observational study
Bruno Verges et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2012)
Update on Insulin Therapy for Type 2 Diabetes
Thomas Donner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Trends of insulin use among US adults with type 2 diabetes: the Behavioral Risk Factor Surveillance System, 1995-2007
Chaoyang Li et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2012)
One-to-many propensity score matching in cohort studies
Jeremy A. Rassen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Matched case-control studies: a review of reported statistical methodology
Daniel Niven et al.
Clinical Epidemiology (2012)
A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens
Lin Xie et al.
ADVANCES IN THERAPY (2011)
A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes
Carl Asche et al.
CLINICAL THERAPEUTICS (2011)
Insulin analogs versus human insulin in type 2 diabetes
Ilias N. Migdalis
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Keeping ahead of the fast pace of science
Juleen R. Zierath
DIABETOLOGIA (2011)
CLINICAL IMPACT OF INITIATING INSULIN GLARGINE THERAPY WITH DISPOSABLE PEN VERSUS VIAL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN A MANAGED CARE SETTING
Stephen N. Davis et al.
ENDOCRINE PRACTICE (2011)
REAL-WORLD OUTCOMES OF INITIATING TWO DIFFERENT BASAL INSULIN THERAPIES VIA DISPOSABLE PENS AMONG PATIENTS WITH TYPE 2 DIABETES IN US EMPLOYER-SPONSORED HEALTH PLANS
J. Du et al.
VALUE IN HEALTH (2011)
Clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine disposable pen versus exenatide BID
Onur Baser et al.
JOURNAL OF MEDICAL ECONOMICS (2011)
Comparison of GE Centricity Electronic Medical Record Database and National Ambulatory Medical Care Survey Findings on the Prevalence of Major Conditions in the United States
Albert G. Crawford et al.
POPULATION HEALTH MANAGEMENT (2010)
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
Peter C. Austin
STATISTICS IN MEDICINE (2009)
A 52-Week, Multinational, Open-Label, Parallel-Group, Noninferiority, Treat-to-Target Trial Comparing Insulin Detemir with Insulin Glargine in a Basal-Bolus Regimen with Mealtime Insulin Aspart in Patients with Type 2 Diabetes
Priscilla Hollander et al.
CLINICAL THERAPEUTICS (2008)
Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes
Athena Philis-Tsimikas et al.
CLINICAL THERAPEUTICS (2006)
Share Paper
